| |
Latest News:
... Latest Story
Further Information:
UMIP - Case Studies of Spin-outs
... Download PDF (940k)
UPF Masterclasses:
NOVEMBER 25th 2008
... More information |
24/10/08
UPF investee Myconostica hires new CEO as it prepares to launch products
Download PDF (80kb)
18/09/08
UPF makes investment in water treatment company, Arvia Technology
Download PDF (40kb)
29/07/08
MTI, in its capacity as fund manager of the UPF, shortlisted for the category "Fund Raising of the Year" at the British Private Equity Awards 2008
02/06/08
Darling meets spin-outs during Manchester visit.
Download PDF (40kb)
01/06/08
MTI, in its capacity as manager of the UPF, shortlisted for the Equity Gap Fund of the Year award at the 2008 Investor Allstars Awards in September 2008
22/05/08
The UPF makes its first investment -
£1m into molecular diagnostics company Myconostica Limited
Download PDF (40kb)
21/05/08
Change of management structure and new appointment at MTI
Download PDF (23kb)
17/04/08
Launch of UPF in Manchester - excerpt from UNILIFE - The magazine of the University of Manchester
Download PDF (3Mb)
17/04/08
BBC Radio Manchester - Interview with Clive Rowland (UMIP) and Torsten Schanze (Nanoco Technologies)
Download MP3 (8Mb)
03/04/08
MTI and The University of Manchester announce the first close of the
UMIP Premier Fund
Download
PDF (45k)
03/04/08
Real Deals - "Out from the Wilderness"
Download
PDF (450k) |
Chancellor Alistair Darling has visited UMIC’s Core Technology Facility building in Manchester to meet two successful biotech spin-outs, one of which, Renovo (LSE:RNVO), successfully emerged from The University of Manchester’s spin-out process nine years ago.
Renovo is a wound treatment company, listed on the London Stock Exchange and valued at approx £300m. The Core Technology Facility was established with NWDA and ERDF funding to provide grow-on incubator space for biotechnology and high-tech early stage companies.
Although Darling was in Manchester to officially launch the Manchester Independent Economic Review - a major study into Manchester’s economic potential – he specifically requested a chance to look around company laboratories and to meet company executives during his visit on June 2.
Professor Mark Ferguson, Renovo’s CEO explains: “We were pleased to show the Chancellor around Renovo including our recent expansion to new facilities on the first floor of the Core Technology Facility. He saw first-hand our development of novel pharmaceutical drugs to reduce scarring and accelerate healing.”
Mark continues: “We discussed the challenges facing biotechnology companies like Renovo. We’ve grown from just 2 founders - Dr Sharon O'Kane and myself – and spun out of The University of Manchester as a private VC backed company in 2000. Renovo now has over 180 full time employees, we are publicly listed on the main list of the London Stock Exchange, and we spend close to £30m per annum on research and development.”
During the Chancellor’s visit, Peter Sanderson, chairman of The University of Manchester Intellectual Property Limited (UMIP) presented an overview of the University’s IP commercialisation activities. Ernie Richardson, CEO of MTI Partners, expressed his enthusiasm for ideas developed at the University now in the process of commercialisation.
MTI Partners are the fund managers for the recently-launched £32m UMIP Premier Fund. Ernie comments: “We have seen evidence of some incredible ideas within the research departments of The University of Manchester. This Fund will enable those researchers to gain access to the finance and business skills to turn their ideas into real business – what could be more exciting?”
|
